The summary covers a range of current health news, including lawsuits, FDA drug approvals, and market trends in medical ...

Once considered low risk, this group is now facing a health crisis. The leading researcher studying AAPI cancer rates tells ...

Gilead Sciences (GILD) ended the recent trading session at $91.86, demonstrating a -0.57% swing from the preceding day's closing price. On the other hand, the Dow registered a loss of 0.2%, and the ...

But truly deleting your personal genetic information from the DNA testing company is easier said than done. The research represents a shift in how we may predict the weather. Jennifer Doudna, the ...

Neurocrine Biosciences won Food and Drug Administration approval late Friday for the first new treatment for an adrenal ...

"Why did I not realize how big [his] head is," one user said, while another added: "The size difference when it changed from [Moonpie] to Callie." ...

Palvella Therapeutics to debut on Nasdaq under the ticker symbol "PVLA” as a publicly traded rare disease biopharmaceutical ...

If you’d gathered at the dinner table with my immediate and extended family when I was growing up, you would have sworn we ...

Some contend that smaller cows are more efficient. They need less feed (so the same number of acres can pasture more cows) ...

Exact Sciences Corporation struggles with profitability due to high expenses. See why EXAS stock faces challenges despite the ...

Top Players Command Over 70% of the CRISPR Market; Products Segment to Gain $4 Billion in Revenues by 2028 CRISPR and Cas ...

High Note: Officially developed in 1992 (though its origins trace back even further), AK-47 embodies NSM’s commitment to ...